MISTY ROWSEY: Open Payments
NPI 1689791733 · CORINTH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,019 in 65 payments from 13 companies in 2025. Trend: 2023 $1,431 · 2024 $1,240 · 2025 $1,019
Food & beverage: $1,019
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $298 |
| PFIZER INC. | 14 | $174 |
| Electromed, Inc. | 6 | $158 |
| Otsuka America Pharmaceutical, Inc. | 5 | $89 |
| Amgen Inc. | 5 | $78 |
| Lilly USA, LLC | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Novo Nordisk Inc | 2 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
Products named: SMARTVEST, AVYCAZ, NURTEC ODT, REXULTI, ELIQUIS, EVENITY, VRAYLAR, MOUNJARO.
Industry payments across MS — which companies pay providers there.
